AU2003258291A8 - Htlv-i p30ii and p12i proteins as therapeutic targets in htvl-i infected individuals - Google Patents

Htlv-i p30ii and p12i proteins as therapeutic targets in htvl-i infected individuals

Info

Publication number
AU2003258291A8
AU2003258291A8 AU2003258291A AU2003258291A AU2003258291A8 AU 2003258291 A8 AU2003258291 A8 AU 2003258291A8 AU 2003258291 A AU2003258291 A AU 2003258291A AU 2003258291 A AU2003258291 A AU 2003258291A AU 2003258291 A8 AU2003258291 A8 AU 2003258291A8
Authority
AU
Australia
Prior art keywords
p30ii
htvl
htlv
proteins
therapeutic targets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003258291A
Other versions
AU2003258291A1 (en
Inventor
Christophe Nicot
Genoveffa Franchini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GOVERNEMENT OF UNITED STAT
Original Assignee
GOVERNEMENT OF UNITED STAT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GOVERNEMENT OF UNITED STAT filed Critical GOVERNEMENT OF UNITED STAT
Publication of AU2003258291A1 publication Critical patent/AU2003258291A1/en
Publication of AU2003258291A8 publication Critical patent/AU2003258291A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
AU2003258291A 2002-08-19 2003-08-19 HTLV-I p30II AND p12I PROTEINS AS THERAPEUTIC TARGETS IN HTVL-I INFECTED INDIVIDUALS Abandoned AU2003258291A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40458002P 2002-08-19 2002-08-19
US60/404,580 2002-08-19
PCT/US2003/025958 WO2004016228A2 (en) 2002-08-19 2003-08-19 HTLV-I p30II AND p12I PROTEINS AS THERAPEUTIC TARGETS IN HTVL-I INFECTED INDIVIDUALS

Publications (2)

Publication Number Publication Date
AU2003258291A1 AU2003258291A1 (en) 2004-03-03
AU2003258291A8 true AU2003258291A8 (en) 2004-03-03

Family

ID=31888381

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003258291A Abandoned AU2003258291A1 (en) 2002-08-19 2003-08-19 HTLV-I p30II AND p12I PROTEINS AS THERAPEUTIC TARGETS IN HTVL-I INFECTED INDIVIDUALS

Country Status (2)

Country Link
AU (1) AU2003258291A1 (en)
WO (1) WO2004016228A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2937741A1 (en) * 2014-01-27 2015-07-30 Theravectys Lentiviral vectors for generating immune responses against human t lymphotrophic virus type 1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627023A (en) * 1993-03-29 1997-05-06 Duke University Suppressor of HIV replication and transcription
US6090783A (en) * 1995-03-24 2000-07-18 Shionogi & Co., Ltd. DNA molecule relating to suppression of gene expression and novel protein

Also Published As

Publication number Publication date
WO2004016228A2 (en) 2004-02-26
AU2003258291A1 (en) 2004-03-03
WO2004016228A3 (en) 2005-03-24

Similar Documents

Publication Publication Date Title
HK1084883A1 (en) 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof
EP1649002A4 (en) Rna processing protein complexes and uses thereof
TWI349551B (en) Thiophenepyrimidinone derivatives and their use in therapy
GB0324429D0 (en) Improvements in and relating to gaming systems
AUPS096302A0 (en) Improvements in and relating to food
AU2003296369A8 (en) Imminoamines and preparation thereof
AU2003295343A1 (en) Uses of human zven proteins and polynucleotides
AU2003226899A8 (en) Human diabetes-mediating proteins
AU2003218261A8 (en) Improvements in pharmaceutical discovery and development
AU2003258291A8 (en) Htlv-i p30ii and p12i proteins as therapeutic targets in htvl-i infected individuals
AU2003284597A1 (en) Apoptosis-associated protein and use thereof
AU2003258134A8 (en) Lung cancer target proteins and use thereof
AU2003209459A1 (en) Protein-protein interactions in human tumours involving bcmp-7 and bcmp-11
AU2003301759A1 (en) Human vps4a and vps4b functions in viral budding
EP1541677A4 (en) Novel proteins and use thereof
EP1577322A4 (en) Novel proteins and use thereof
AUPS243002A0 (en) Therapeutic target and uses thereof
AU2003251763A1 (en) Interferon gamma in the detection and treatment of angiomyolipomas
AU2003263751A8 (en) Novel proteins and their uses
AU2003265814A8 (en) Aw755252-interacting proteins and use thereof
AU2002226691A1 (en) Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby
EP1284288A4 (en) Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby
AU2003230818A1 (en) PrLZ REGULATORY ELEMENTS IN THE TREATMENT OF DISEASE AND THE DISCOVERY OF THERAPEUTICS
AU2003285877A8 (en) Novel proteins and their uses
PL1693378T3 (en) Protein nmb1125 and use thereof in pharmaceutical formulations

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase